BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 13159015)

  • 1. [Notes about the effectiveness of suppressive Daraprim compared with that of camoquine and nivaquine].
    CAMPHYN R
    Ann Soc Belg Med Trop (1920); 1953 Dec; 33(6):553-61. PubMed ID: 13159015
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the antimalarial effects of suppressive doses of chloroquine, amodiaquin, and pyrimethamine.
    MILLER MJ
    Am J Trop Med Hyg; 1954 May; 3(3):458-63. PubMed ID: 13158765
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change.
    Basco LK; Ngane VF; Ndounga M; Same-Ekobo A; Youmba JC; Abodo RT; Soula G
    Am J Trop Med Hyg; 2006 Sep; 75(3):388-95. PubMed ID: 16968911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2 cases of multiresistant Plasmodium falciparum malaria contracted in Douala with atypical clinical presentation].
    Charmot G; Simon F; Le Bras J
    Bull Soc Pathol Exot Filiales; 1987; 80(3 Pt 2):447-51. PubMed ID: 3319253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986.
    Schapira A; Schwalbach JF
    Bull World Health Organ; 1988; 66(2):219-26. PubMed ID: 3293827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new antimalarial drugs.
    Powell RD
    Am J Trop Med Hyg; 1972 Sep; 21(5):744-8. PubMed ID: 4561522
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.
    Tagbor H; Bruce J; Browne E; Randal A; Greenwood B; Chandramohan D
    Lancet; 2006 Oct; 368(9544):1349-56. PubMed ID: 17046467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria chemoprophylaxis.
    Drug Ther Bull; 1971 Apr; 9(9):33-6. PubMed ID: 5575697
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population.
    Hagos B; Khan B; Ofulla AV; Kariuki D; Martin SK
    East Afr Med J; 1993 Oct; 70(10):620-3. PubMed ID: 8187656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of chloroquine or amodiaquine in combination with sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Papua New Guinea.
    Jayatilaka KD; Taviri J; Kemiki A; Hwaihwanje I; Bulungol P
    P N G Med J; 2003; 46(3-4):125-34. PubMed ID: 16454394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
    Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
    Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda.
    Nevill CG; Ochen K; Munafu CG; Bekobita D; Sezi CL
    East Afr Med J; 1995 Jun; 72(6):349-54. PubMed ID: 7498001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
    Niklewski G; Landscheidt H; Glasner H
    Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malaria chemoprophylaxis. Resistance problems].
    Danis M; Gentilini M
    Arch Fr Pediatr; 1985 Dec; 42 Suppl 2():971-5. PubMed ID: 3914247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
    Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
    Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of drugs in a malaria program.
    Bruce-Chwatt LJ
    Am J Trop Med Hyg; 1972 Sep; 21(5):731-5. PubMed ID: 5074690
    [No Abstract]   [Full Text] [Related]  

  • 20. Chloroquine-resistant falciparum malaria from Irian Jaya (Indonesian New Guinea).
    Clyde DF; McCarthy VC; Miller RM; Hornick RB
    J Trop Med Hyg; 1976 Feb; 79(2):38-41. PubMed ID: 775119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.